Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Creatine as a Treatment Option for Depression in Methamphetamine Using Females

NCT01514630 is registered in ClinicalTrials.gov with Perry Renshaw as lead sponsor.

NCT NCT01514630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01514630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Creatine as a Treatment Option for Depression in Methamphetamine Using Females
Lead sponsor
Perry Renshaw
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
February 28, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, dual diagnosis, neuroimaging, substance abuse, substance use